Search Results - "Wasif, Saif"
-
1
Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes
Published in JNCI : Journal of the National Cancer Institute (18-11-2009)“…Chemotherapy dosing of the fluoropyrimidine 5-fluorouracil (5-FU) is currently based on body surface area. However, body surface area–based dosing has been…”
Get full text
Journal Article -
2
Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
Published in Journal of clinical oncology (20-07-2008)“…To evaluate the safety and efficacy of three oxaliplatin and fluoropyrimidine regimens, with or without bevacizumab, as first-line treatment for metastatic…”
Get full text
Journal Article -
3
The Role of Src in Colon Cancer and Its Therapeutic Implications
Published in Clinical colorectal cancer (01-03-2014)“…Abstract Src is a member of a superfamily of membrane-associated nonreceptor protein tyrosine kinases. It is stimulated by receptors of growth hormone,…”
Get full text
Journal Article -
4
Disparities in colorectal cancer in African-Americans vs Whites: Before and after diagnosis
Published in World journal of gastroenterology : WJG (14-08-2009)“…There are differences between African-American and white patients with colorectal cancer, concerning their characteristics before and after diagnosis. Whites…”
Get full text
Journal Article -
5
Cutaneous Metastasis of Primary Small Intestinal Neuroendocrine Tumor: 2496
Published in The American journal of gastroenterology (01-10-2018)“…Introduction: Neuroendocrine tumors (NETs) are neoplasms commonly found within the gastrointestinal tract (GIT) that originate from endocrine cells. These are…”
Get full text
Journal Article -
6
Gastrointestinal perforation due to bevacizumab in colorectal cancer
Published in Annals of surgical oncology (01-06-2007)“…Bevacizumab is the first U.S. Food and Drug Association-approved vascular endothelial growth factor-targeted agent that greatly increases progression-free and…”
Get full text
Journal Article -
7
Neoadjuvant therapy for pancreatic cancer: an ongoing debate
Published in Therapeutic advances in gastroenterology (01-07-2016)Get full text
Journal Article -
8
Treatment of Locally Advanced Pancreatic Cancer: The Role of Radiation Therapy
Published in International journal of radiation oncology, biology, physics (01-02-2012)“…Pancreatic cancer remains associated with an extremely poor prognosis. Surgical resection can be curative, but the majority of patients present with locally…”
Get full text
Journal Article -
9
The role of mTOR in the management of solid tumors: An overview
Published in Cancer treatment reviews (01-04-2009)“…Summary Mammalian target of rapamycin (mTOR) is a key protein kinase controlling signal transduction from various growth factors and upstream proteins to the…”
Get full text
Journal Article -
10
Management of Pancreatic Cancer During COVID-19 Pandemic: To Treat or Not to Treat?
Published in Journal of the Pancreas (2020)“…Pancreatic cancer is a very aggressive disease and survival remains dismal even with treatment. Currently, management of patients with pancreatic cancer has…”
Get full text
Journal Article -
11
Role of Pregabalin in Treatment of Oxaliplatin-induced Sensory Neuropathy
Published in Anticancer research (01-07-2010)“…Oxaliplatin use in gastrointestinal malignancies is limited by neurotoxicity. This study aimed to assess the efficacy of pregabalin (LYRICA(R)) in the…”
Get full text
Journal Article -
12
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer
Published in Therapeutic Advances in Medical Oncology (01-03-2013)“…Gastric cancer remains difficult to cure and has a poor overall prognosis. Chemotherapy and multimodality therapy has shown some benefit in the treatment of…”
Get full text
Book Review Journal Article -
13
Selecting treatment options in refractory metastatic colorectal cancer
Published in OncoTargets and therapy (01-01-2019)“…Survival of patients with metastatic colorectal cancer (mCRC) has significantly improved in the last decade. Survival gains are not driven by advances in…”
Get full text
Journal Article -
14
Small cell carcinoma of the colon arising in a carcinoid tumor
Published in Anticancer research (01-04-2013)“…Small cell carcinomas of the gastrointestinal tract are rare and clinically aggressive tumors. A case is presented of a 70 year-old woman who presented with…”
Get full text
Journal Article -
15
Update on the role of nanoliposomal irinotecan in the treatment of metastatic pancreatic cancer
Published in Therapeutic Advances in Gastroenterology (01-07-2017)“…Median survival for patients with metastatic pancreatic cancer (MPC) treated with combination chemotherapeutic agents such as gemcitabine-based regimens and…”
Get full text
Book Review Journal Article -
16
Adenocarcinoma ex goblet cell carcinoid in a renal transplant patient: a case report and review of the literature
Published in Anticancer research (01-04-2013)“…Adenocarcinoma ex goblet cell carcinoid is a rare neoplasm of appendiceal origin that contains features of both carcinoid tumor and adenocarcinoma. We report…”
Get full text
Journal Article -
17
Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer
Published in Therapeutic Advances in Medical Oncology (01-09-2012)“…Pancreatic cancer has historically proven resistant to anticancer agents. On the one hand, drugs might be more efficient if higher levels could be achieved at…”
Get full text
Book Review Journal Article -
18
Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer
Published in Therapeutic advances in gastroenterology (2020)“…Background: Treatment with gemcitabine/nab-paclitaxel confers a survival benefit over gemcitabine monotherapy in patients with advanced pancreatic cancer…”
Get full text
Journal Article -
19
A DPYD Variant (Y186C) Specific to Individuals of African Descent in a Patient With Life-Threatening 5-FU Toxic Effects: Potential for an Individualized Medicine Approach
Published in Mayo Clinic proceedings (2014)“…Abstract 5-Fluorouracil (5-FU) is commonly administered as a therapeutic agent for the treatment of various aggressive cancers. Severe toxic reactions to 5-FU…”
Get full text
Journal Article -
20
New Drug and Possible New Toxicity - Squamous Cell Carcinoma Following Imatinib in Patients with Gastrointestinal Stromal Tumors
Published in Anticancer research (01-11-2016)“…Molecularly targeted therapy has revolutionized the treatment of advanced gastrointestinal stromal tumors (GISTs). Specifically, the consistent dependence of…”
Get full text
Journal Article